Carlat Report
Article
Carlat Report is a recurring publication in the Astral Codex Ten archive, appearing 2 times across 2 issues between May 25, 2021 and May 18, 2022. The archive places it in contexts such as “source is here , but you won’t be able to read it without a Carlat Report subscription”; “the Carlat Report says nice things about it”; “Where did Carlat Report’s 0.86 effect size come from?“. It most often appears alongside quetiapine, SSRIs, 2002 meta-analysis by Cochrane Collaboration.
Metadata
- Category: Publications
- Mention count: 2
- Issue count: 2
- First seen: May 25, 2021
- Last seen: May 18, 2022
Appears In
Related Pages
-
- quetiapine (2 shared issues)
-
- SSRIs (2 shared issues)
-
- 2002 meta-analysis by Cochrane Collaboration (1 shared issues)
-
- 5-HTP (1 shared issues)
-
- 5-HTP (1 shared issues)
-
- ADHD (1 shared issues)
-
- amitriptyline (1 shared issues)
-
- Andrea Cipriani (1 shared issues)
-
- Angelini (1 shared issues)
-
- AOP Orphan Pharmaceuticals AG (1 shared issues)
-
- Apple (1 shared issues)
-
- aripiprazole (1 shared issues)
External Links
Source Context
Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.
Here’s the diet the study used (source is here, but you won’t be able to read it without a Carlat Report subscription):
Inline links: here
Intellicare is a series of CBT apps; you can download it for free as “Intellicare Hub” here or on the Google or Apple stores. I have never tried it, but the Carlat Report says nice things about it, and it has several successful studies under its belt.
Inline links: here, several successful studies
But recently silexan (derived from lavender) has started to stand out of the crowd. Daily Mail had an interview with psychiatry professor Hans-Peter Volz, who said that silexan should be first-line for anxiety, replacing things like SSRIs and Xanax. And a very reputable professional publication within psychiatry, The Carlat Report, published an article and a podcast touting silexan:
Studies claim it to be highly effective against anxiety conditions. Carlat Report offers us the following data (table layout is mine):
(Where did Carlat Report’s 0.86 effect size come from? Supposedly from the Generoso meta-analysis’s sub-analysis of only GAD patients, but I can’t for the life of me retrace how they got that number.)
Inline links: Generoso meta-analysis